Neoplasia/BPH

	Efficacy and safety of immune checkpoint inhibitors combined with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: a risk-stratified systematic review and meta-analysis. Front Immunol Rao Y, Zhang J, Gu X, Han J, Ye Z. PMID: 42220544 [PubMed - as supplied by publisher]
	Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes. Front Immunol Chen ST, Zhou DR, Ge YJ, Chang L, Guo SH, Wu GS, Feng NH. PMID: 42220493 [PubMed - as supplied by publisher]
	Identification of succinylation-related genes in bladder cancer: integration of single-cell and transcriptomic data. Front Immunol Yang J, You Z, Mo H, Pu J, Shen G, Miao Z. PMID: 42220482 [PubMed - as supplied by publisher]
	Radiomics-Based Machine Learning versus the MAP Score for Predicting Haematocrit Decline after Laparoscopic Partial Nephrectomy. J Coll Physicians Surg Pak Dogan Y, Ozdes AA, Yildirim M, Beler M, Kartal D, Pirincci N. PMID: 42219835 [PubMed - indexed for MEDLINE]
	Investigating Setup Error Differences between Conventional and Ultra-Hypofractionated Whole Pelvis Radiation Therapy: A Secondary Analysis from the HOPE Randomized Clinical Trial. J Appl Clin Med Phys Schaly B, Mendez LC, Khawaja M, Black A, Warner A, Hoover DA. PMID: 42219614 [PubMed - indexed for MEDLINE]
	Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase 2a PLANETTE Study. Cancer Res Commun Aggarwal RR, Italiano A, Domchek SM, Goodman O, Postel-Vinay S, García-Donás J, Dorff T, Reichert ZR, Vinceneux A, Shore N, Marshall CH, Armenia J, Parr G, Kmieciak A, Lukashchuk N, Murina O, Slade D, Shah N, Loembé B, Dean E, Sanai E, Abida W. PMID: 42219553 [PubMed - as supplied by publisher]
	Histotripsy-induced acute kidney injury following liver tumor treatment: A preliminary report of 9 cases. J Vasc Interv Radiol Poe LL, Kisting AL, Mendiratta-Lala M, Abi-Jaoudeh N, Breuer JA, Fidelman N, Raman SS, Lee FT Jr, Lokken RP, Caoili EM, Shah R, Hinshaw JL. PMID: 42218940 [PubMed - as supplied by publisher]
	Impact of control selection strategies on GWAS results: a study of prostate cancer in the UK biobank. Brief Bioinform Lu J, Thygesen JH, Beaumont RN, Weedon MN, Green HD. PMID: 42218711 [PubMed - in process]
	Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients. Jpn J Clin Oncol Ichiyama T, Narita T, Sekine Y, Shinohara M, Kawashima Y, Kobayashi M, Numakura K, Mikami J, Fujita N, Okamoto T, Yamamoto H, Narita S, Sato S, Habuchi T, Ohyama C, Hatakeyama S. PMID: 42218684 [PubMed - as supplied by publisher]
	Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial. J Clin Oncol Necchi A, de Jong JJ, Maiorano BA, Proudfoot JA, Basile G, Cigliola A, Mercinelli C, Tateo V, Piacentini M, Crupi E, Pastorino GL, Latini G, Tomasi E, Davicioni E, Moschini M, Brembilla G, Colecchia M, de Cobelli F, Ross JS, Madison R, Tambaoan CFB, Briganti A, Montorsi F. PMID: 42218654 [PubMed - as supplied by publisher]
	Cytoreductive radical prostatectomy in patients with high-volume metastatic prostate cancer achieving deep biochemical response to contemporary systemic therapy: a multicentre, prospective cohort study. BMC Med Huang C, Guo H, Gao W, Huang M, Ji G, Rui R, He S, Yu Y, Zhang N, Tian Y, Niu Y, Li X, Zhou L. PMID: 42218463 [PubMed - as supplied by publisher]
	Exploring the functional role of palmitoylation genes in clear cell renal cell carcinoma and their impact on tumor microenvironment. BMC Genom Data Li J, Chang H, Xu H, Bai Y, Tang W. PMID: 42218414 [PubMed - as supplied by publisher]
	Real-World Comparative Effectiveness and Safety of Immune Checkpoint Inhibitors in Advanced Renal Cell Carcinoma: A Systematic Review. Target Oncol Yiu CH, Leung GYY, Lee IC, Lu CY. PMID: 42218357 [PubMed - as supplied by publisher]
	Primary site- and metastasis-directed therapies in patients with metastatic prostate cancer: A narrative review. Int J Clin Oncol Goto T, Mizuno K, Sumiyoshi T, Kita Y, Masui K, Ogata T, Aizawa R, Sawada A, Saito R, Mizowaki T, Kobayashi T. PMID: 42218356 [PubMed - as supplied by publisher]
	Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet Trial. Eur Urol Focus Kostos L, Buteau JP, Azad AA, Hofman MS. PMID: 42218070 [PubMed - as supplied by publisher]
	New Paradigms in Theranostics of Prostate Cancer: The Rise of Î±-Emitters and Next-generation Targets. Eur Urol Focus Deandreis D, Deutsch E. PMID: 42218069 [PubMed - as supplied by publisher]
	Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder Cancer. Front Biosci (Landmark Ed) Abou Chakra M, Duquesne I, O'Donnell MA. PMID: 42216552 [PubMed - indexed for MEDLINE]
	Bayesian Evaluation of Treatment Effect of Avelumab Plus Axitinib for Advanced Renal Cell Carcinoma. Cancer Med Fukuokaya W, Mori K, Yanagisawa T, Ito K, Imai Y, Urabe F, Rajwa P, Shariat SF, Kimura T, Hirakawa A. PMID: 42216439 [PubMed - indexed for MEDLINE]
	Top advances of the year: Radiopharmaceutical therapy for prostate cancer. Cancer Marulanda-Corzo V, Coraci S, Kakkar P, Okobi TJ, Huicochea-Castellanos S, Osborne JR, Tagawa ST. PMID: 42216431 [PubMed - indexed for MEDLINE]
	Association of DNA damage repair related genes with prostate cancer: A multi-omics Mendelian Randomization analysis. Medicine (Baltimore) Xie H, Ban C, Su Z, Huang Q, Tang H, Cheng Z, Liao T, Liao K, Yi X. PMID: 42216412 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 188273

Page 1 of 9414



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy